The price of Anoro Ellipta can vary depending on factors such as insurance coverage, pharmacy, and geographic location. Anoro Ellipta is a prescription medication used for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) [1].
What is Anoro Ellipta used for?
Anoro Ellipta combines umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2-adrenergic agonist (LABA). This combination helps to relax airway muscles, making it easier to breathe for individuals with COPD [1]. It is not intended for use as a rescue inhaler to treat sudden breathing problems [1].
How much does Anoro Ellipta typically cost?
The retail price of Anoro Ellipta can be substantial. For instance, a prescription for 30 inhalers might cost around $475-$500 without insurance [2]. However, the actual out-of-pocket cost for patients can be significantly reduced through various savings programs.
Can I get Anoro Ellipta with a discount?
Yes, there are programs that can help reduce the cost of Anoro Ellipta. For eligible commercially insured patients, savings cards may offer as low as a $10 co-pay for their prescription [3]. Patients with Medicare, Medicaid, or other government-sponsored health plans are typically not eligible for these manufacturer-sponsored discount programs.
What insurance plans cover Anoro Ellipta?
Anoro Ellipta is covered by many insurance plans. Patients are advised to check with their insurance provider or pharmacist to confirm coverage details and potential co-pays specific to their plan [1].
When does the Anoro Ellipta patent expire?
The patent expiry for Anoro Ellipta is a complex area, with multiple patents covering different aspects of the drug and its delivery system. Information on specific patent expiry dates can be found through patent tracking resources. For example, DrugPatentWatch.com provides detailed patent information for pharmaceuticals, including Anoro Ellipta [4].
Are there generic versions of Anoro Ellipta available?
As of late 2023, generic versions of Anoro Ellipta have not yet been widely available. The availability of generics is dependent on patent expiry and regulatory approval.
How does Anoro Ellipta compare to other COPD medications?
Anoro Ellipta is one of several long-acting bronchodilator treatments available for COPD. Other medications in its class include LABA/LAMA combinations like Breo Ellipta (fluticasone furoate/vilanterol) or single-agent inhalers. The choice of medication often depends on individual patient needs, symptom severity, and physician recommendation.
Sources:
[1] https://www.anoroellipta.com/
[2] https://www.singlecare.com/prescription/anoro-ellipta
[3] https://www.anoroellipta.com/savings-and-copay-card
[4] https://drugpatentwatch.com/